maxgraft® Granula - prozessiertes Allograft

maxgraft® granules

Processed allograft
maxgraft® is a sterile, high-safety allograft product, derived from human-donor bone, processed by Cells+Tissuebank Austria (C+TBA). C+TBA, a high-quality bone bank, is regulated, audited, and certified by the Austrian Ministry of Health and fulfills the highest EU safety standards.
  • Extraction socket
  • Ridge augmentation
  • Osseous defects
  • Intraosseous defects (1-3 walls)
  • Sinus floor elevation

Rehydration

The processing of maxgraft® products preserves the natural collagen content and a residual water content of <10%. Thus, a rehydration is not mandatory. However, rehydration in blood or saline solution can facilitate the handling and application of maxgraft® granules due to better sticking together.

Particle application

Avoid compressing the particles excessively during application; less packed particles leave more space for blood vessel ingrowth and formation of new bone matrix.

Mixing with autologous bone

Mixing of maxgraft® granules with autologous bone adds a biological activity (osteoinductive and osteogenetic properties of autologous bone) and supports faster regeneration and formation of new bone.

Mixing with cerabone®

Mixing of maxgraft® granules with xenogenic materials (cerabone®) combines the advantages of both materials; the biological potential of maxgraft® and the long-term volume stability of cerabone® lead to fast regeneration of strong vital bone.

Re-entry

Depending on the defect size, the graft will be incorporated stable within 3-4 months (usage of maxgraft® granules in socket preservation, smaller bone defects, periodontal defects).

Socket preservation with mucoderm® & maxgraft® - Dr. A. Puisys

Pre-operative situation; tooth 21 proved not to be worth preserving

Full bone regeneration in extraction socket augmented with maxgraft® and Jason® membrane – Dr. C. Landsberg

Initial clinical situation: 9 mm pocket depth associated with root fracture

botiss-cerabone-permamem-maxgraft-mucoderm-horizontal-gbr-maghaireh

Initial situation - A young female 34 years old lost her front teeth in an surfing accident and she had a 5 unit bridge supported by her upper left lateral and right canine. The restoration failed and both supporting crowns have exposed and leaking margins.

Simultaneous GBR and implantation using maxgraft® granules and autologous bone

Initial situation - endodontically failing tooth 22, very thin biotype, high lip line and esthetic expectations

  • Preserved biomechanical properties
  • Sterile – no antigenic effects
  • Storable at room temperature for 5 years
  • Osteoconductive properties supporting natural
    and controlled tissue remodelling

maxgraft® cancellous granules

Article Number

Particle Size

Content

30005

< 2.0 mm

1 x 0.5 ml

30010

< 2.0 mm

1 x 1.0 ml

30020

< 2.0 mm

1 x 2.0 ml

30040

< 2.0 mm

1 x 4.0 ml

maxgraft® cortico-cancellous granules

Article Number

Particle Size

Content

31005

< 2.0 mm

1 x 0.5 ml

31010

< 2.0 mm

1 x 1.0 ml

31020

< 2.0 mm

1 x 2.0 ml

31040

< 2.0 mm

1 x 4.0 ml

C+TBA Allografts: Presenting the Allotec® process
C+TBA Allografts: Presenting the Allotec® process
Dr. Frank Kloss about maxgraft®
Dr. Frank Kloss about maxgraft®
maxgraft® granules - Processed allograft
maxgraft® granules - Processed allograft

For experienced oral and maxillofacial surgeons, allograft bone is  the only real alternative to harvesting the patient’s own autologous bone. This helps preventing well known risks such as donor-site morbidity, infection, post-operative pain, and bone-stability loss. The excellent biological regeneration capability of maxgraft® results in a predictable clinical outcome.

[1] Tilaveridis I. et al, The use of mineralized bone allograft (C+TBA) as a single grafting material in maxillary sinus lifting with severely atrophied alveolar ridge (1–3mm) and immediately inserted dental implants. A 3- up to 8-year retrospective study, 2018 Oral and Maxillofacial Surgery, Sep;22(3):267-273.
[2] Simonpieri A. et al. Four-year post-loading results of full-arch rehabilitation with immediate placement and immediate loading implants: A retrospective controlled study. Quintessence Int. 2017;48(4):315-324.